Volume 18, Number 1—January 2012
Emergence of Blastoschizomyces capitatus Yeast Infections, Central Europe
|Patient no.||MIC, μg/mL
*AMB, deoxycholate amphotericin B; 5-FC, 5-fluorocytosine; FLC, fluconazole; ITC, itraconazole; VRC, voriconazole; POS, posaconazole; CAS, caspofungin.
†By Etest (bioMérieux, Marcy l’Etoile, France), the isolate had an AMB MIC of 3 μg/mL.
- Page created: December 19, 2011
- Page last updated: December 19, 2011
- Page last reviewed: December 19, 2011
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)